WHO WE ARE ?

Curannova Pharmaceutical was founded in 2019 with a mission of making an exceptional difference in our patients· lives by enabling people to lead a healthy, good quality life. We pay extra attention to details to fill the gaps between the patients and their cure.

At Curannova, we identify, develop, and commercializing meaningful products that address unmet medical needs in the Egyptian pharmaceutical industry.

We are here to make a noticeable modification in the therapeutic areas that can leverage our unique expertise through a growth strategy of the existing medicines, acquiring commercial products or product candidates that are in late-stage development, and pursuing focused development of our pipeline of differentiated therapies.

So far, our portfolio that focuses on the areas of arthritis, Diabetes, and GIT is remarkable, and it’s growing by the day.

Our vision

We are continually consolidating our position as one of the leading generic pharmaceutical companies worldwide, and we are achieving this on our own by strengthening the long-term business connections and by establishing partnerships in the fields of development, product supply and marketing. All of this so we can deliver the best healthcare possible to every patient in need. It’s a working process yet a vivid vision coming to life with each passing day and every treated patient.

Our
Culture

At Curannova Pharmaceuticals, we believe that exceptional care comes within exceptional people with diverse pharmaceutical, chemical, and biotechnology backgrounds and customer service orientation who are devoting their efforts, eagerness, and conscience to identify our mission, vision, and core values.

With these outstanding high-performance teams, we shall continue to fulfill our mission of expanding our production of high-quality products to satisfy the needs of our community.